Lincoln Pharmaceuticals informs about disclosure

30 Nov 2022 Evaluate

Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanibhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

621.00 -4.75 (-0.76%)
13-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1506.90
Dr. Reddys Lab 6087.65
Cipla 1543.45
Zydus Lifesciences 1093.00
Lupin 1608.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.